lactic acid and tetraiodothyroacetic acid

lactic acid has been researched along with tetraiodothyroacetic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bharali, DJ; Davis, FB; Davis, PJ; Dyskin, E; Hercbergs, A; Lansing, L; Mousa, SA; Mousa, SS; Yalcin, M1
Bharali, DJ; Bridoux, A; Davis, FB; Davis, PJ; Dyskin, E; Glinskii, A; Glinsky, GV; Hercbergs, AH; Lansing, L; Lin, HY; Ma, J; Mousa, SA; Mousa, SS; Yalcin, M1
Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M1
Bharali, DJ; Darwish, NH; Davis, PJ; Debreli Coskun, M; Keating, KA; Lin, HY; Mousa, SA; Sudha, T; Yalcin, M1

Other Studies

4 other study(ies) available for lactic acid and tetraiodothyroacetic acid

ArticleYear
Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
    Anticancer research, 2009, Volume: 29, Issue:10

    Topics: Animals; Carcinoma, Renal Cell; Cell Growth Processes; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Humans; Kidney Neoplasms; Lactic Acid; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays

2009
Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:4

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Medullary; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Excipients; Female; Hemoglobins; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Thyroid Neoplasms; Thyroxine; Xenograft Model Antitumor Assays

2010
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
    Nanomedicine (London, England), 2013, Volume: 8, Issue:12

    Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine

2013
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Dynamic Light Scattering; Female; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Paclitaxel; Pancreatic Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays

2017